@chairpotato62
Active 3 months, 3 weeks ago
From 10 to 15 years back to date, treatments for AML relapsing after HSCT had been limited to main-stream cytotoxic chemotherapy and donor leukocyte infusions (DLI). Nowadays, novel agents and targeted therapies have enriched the healing landscape. More over, really recently, the healing landscape is enriched by manipulated mobile items (CAR-T, […] View